Fujifilm’s REiLI® Artificial Intelligence Platform Now in Clinical Use for Intracranial Hemorrhage and Breast Cancer Detection and Diagnosis – Yahoo Finance

Health systems use REiLI in clinical practice along with third-party algorithm developers ScreenPoint Medical and MaxQ AI
Lexington, Mass., Nov. 23, 2021 (GLOBE NEWSWIRE) — November 23, 2021FUJIFILM Healthcare Americas Corporation, a leading provider of diagnostic and enterprise imaging solutions, announced two of its customers are using the company’s REiLI Artificial Intelligence (AI) platform in clinical practice. Capital Health of Pennington, NJ is using this platform for a solution that automatically and rapidly identifies and prioritizes suspected Intracranial Hemorrhage (ICH) for potential stroke patients, and the University Radiology Group (URG) located throughout New Jersey is using the platform to support their accelerated detection and diagnosis of breast cancer.
“Fujifilm strategically developed REiLI as an open, vendor-neutral platform that manages workflow and delivers AI results through our Synapse 7x diagnostic applications,” said Bill Lacy, senior vice president, medical informatics, FUJIFILM Healthcare Americas Corporation. “This is the answer for Synapse customers as to how they can connect Fujifilm-developed, or in the case of Capital Health and URG, third-party algorithm results directly into their Synapse PACS diagnostic workflow in the most impactful ways to accelerate clinical decisions.”
AI for Intracranial Hemorrhage Detection
ICH is the second most common subtype of stroke and typically leads to severe disability or death. Experts say only 12 to 39 percent of survivors can achieve long-term functional independence, and the overall incidence of spontaneous ICH in the U.S. is significant—with approximately 40,000 to 67,000 cases each year. With traumatic brain injury and stroke, early detection and treatment of hemorrhage leads to improved outcomes and can mean the difference between life and death.
With expertise in advanced imaging and treatment of vascular disease, Dr. Choudhri, director of vascular and interventional radiology and assistant director of radiology at Capital Health, and his team of neuroradiologists, are using REiLI to enable MaxQ AI’s Accipio Suite. The combination of REiLI and Accipio Suite provides comprehensive, seamless and secure assessment of non-contrast head CT for ICH prioritization, triage, annotation, quantification and rule-out, which can result in the automatic and rapid identification and prioritization of potential stroke patients.
AI for Breast Cancer Detection and Diagnosis
URG is now leveraging REiLI to access ScreenPoint Medical’s Transpara – an AI solution designed to help radiologists improve reading accuracy, reduce reading time and improve workflow. Mammographers at URG access Transpara through Fujifilm’s REiLI platform to support their detection and diagnosis of breast cancer.
“Fujifilm has been a key enterprise imaging partner of ours for 15 years, so exploring the capabilities of their AI platform was a natural next step in our collaborative journey to improving patient care,” says Richard Epstein, M.D., chief medical information officer, University Radiology Group. “We are now using REiLI and Transpara in four of our mammography centers and are looking forward to expanding across all of our centers next quarter.”
URG prioritized mammography in their exploration of AI because 2D and 3D breast imaging tend to be high volume studies. Epstein continues, “mammography lends itself to earlier adoption when it comes to Artificial Intelligence, because there is a long history of people already using computer aided diagnosis, so it was a natural advancement to provide our mammographers with this technology to support their diagnostic workflows.”
More than 270,000 women are diagnosed with breast cancer every year in the United States, and more than 40,000 women will die from the disease over the same period. Diagnosis at an early stage due to routine screenings, represents one of the most important prognostic factors for survival.
New studies find that the use of AI in breast cancer screening could reduce the workload of radiologists by up to 70%, without reducing cancer detection. Additionally, ScreenPoint Medical’s latest clinical studies of its AI solution have confirmed major new benefits for radiologists and their patients, including up to 35% of exams with interval cancers found on earlier mammograms, up to 70% of exams can now be confidently labelled as most likely normal to help reduce workload for increasingly pressured radiologists, improve efficiency and more.
REiLI will be available for demonstration at the 2021 Radiological Society of North America (RSNA) conference, booth #1911, held from November 28 – December 2, 2021 at McCormick Place West in Chicago. To learn more about Fujifilm’s presence at RSNA 2021 and to schedule an on-site meeting, please visit: http://rsna.fujimed.com/
About Fujifilm
FUJIFILM Healthcare Americas Corporation is a leading innovator in diagnostic and enterprise imaging solutions designed to meet the evolving needs of healthcare across prevention, diagnosis, and treatment. Fujifilm’s medical imaging portfolio includes solutions for digital radiography, mammography, computed tomography, magnetic resonance imaging, ultrasound, endoscopy, and endosurgery. The Synapse® Enterprise Imaging portfolio provides healthcare professionals with the imaging and data access needed to deliver a complete patient record. REiLI®, Fujifilm’s artificial intelligence initiative, combines Fujifilm’s rich image -processing heritage with cutting-edge AI innovations to inspire a new tier of clinical confidence. The In-Vitro Diagnostic portfolio provides the golden standard of molecular based immunoassay technology for liver surveillance, cutting edge clinical diagnostic chemicals for leading laboratories across the country and diagnostic chemicals for OEM white labeling products. The company is headquartered in Lexington, Massachusetts. For more information please visit healthcaresolutions-us.fujifilm.com.
FUJIFILM Holdings Corporation, Tokyo, Japan, brings cutting edge solutions to a broad range of global industries by leveraging its depth of knowledge and fundamental technologies developed in its relentless pursuit of innovation. Its proprietary core technologies contribute to the various fields including healthcare, highly functional materials, document solutions and imaging products. These products and services are based on its extensive portfolio of chemical, mechanical, optical, electronic and imaging technologies. For the year ended March 31, 2021, the company had global revenues of $21 billion, at an exchange rate of 106 yen to the dollar. Fujifilm is committed to responsible environmental stewardship and good corporate citizenship. For more information, please visit: www.fujifilmholdings.com

Tonix Pharmaceuticals (NASDAQ: TNXP), a rather up-and-down meme stock in the biotech sector, was having a fine day on the market Tuesday. Tuesday morning, Tonix was all too happy to announce that the Food and Drug Administration (FDA) has cleared the Investigational New Drug application for its TNX-1900. The treatment of migraines has been a thorny challenge for biotechs and pharmaceutical companies for many years.
Aadi Bioscience snagged its first FDA approval on Tuesday for a drug that treats a rare form of cancer — but the biotech stock fell.
The CEO of the defunct blood-testing startup took aim at prosecutors’ most serious allegations against her, offering a narrative of herself as a well-intentioned if inexperienced entrepreneur.
Sometimes, it can feel like the coronavirus pandemic is waning, since we're all tired of hearing about it, and so much of the country is vaccinated. However, cases are going up and experts are predicting a "winter wave" and just yesterday, Rochelle Walensky, the director of the CDC, reviewed some startling statistics about who is more vulnerable to a COVID infection, and who is most likely to die from contracting it. Read on for her guidance about this, and also about rising cases and how to sta
A new vaccine designed to specifically create T-cells against Covid produces a better immune response than the alternatives already in use, according to trial data.
The recent acquisition of Dicerna Pharmaceuticals makes Arrowhead Pharmaceuticals look like the next biotech in line to receive a juicy buyout offer.
The average annual salary for registered nurses, not including bonus pay such as overtime, increased about 4% this year to $81,376, according to an analysis.
The FDA has accepted Bluebird bio Inc's (NASDAQ: BLUE) marketing application for betibeglogene autotemcel (beti-cel) for β-thalassemia. The agency has granted priority review for Beti-cel, gene therapy for β-thalassemia across all genotypes who require regular red blood cell transfusions. If approved, beti-cel will be the first one-time treatment that addresses the underlying genetic cause of disease—offering an alternative to regular RBC transfusions and iron chelation therapy. The agency has s
An Oak Grove mother has died from COVID-19 complications after her whole family came down with the virus.
Is Merck stock a buy after its Covid pill, molnupiravir, offers a new hope in the fight against Covid-19? Is MRK stock a buy now?
Vice President Kamala Harris on Monday called for a health care workforce that "looks like America" and said the COVID-19 pandemic has exposed the systemic inequities in the health care system.
Photo Illustration by The Daily Beast/Photos YouTubeTo hear the fringe doctors who gathered at an equine facility for the Florida COVID Summit earlier this month, ivermectin is as effective against the virus in humans as it is against worms in horses.“I have been on ivermectin for 16 months, my wife and I,” Dr. Bruce Boros declared at the end of the meeting at the World Equestrian Center in Ocala. “I have never felt healthier in my life.”Two days later, the 71-year-old cardiologist fell ill with
Shannon Stapleton via ReutersIn May and July 2018, two British women died of catastrophic herpes infections shortly after delivering babies via Caesarean section in facilities overseen by the East Kent Hospitals Trust. Their grieving families were told nothing connected them.But an investigation conducted by the BBC has learned otherwise—the women shared a surgeon who may have unknowingly planted the herpes virus directly into their uteruses after he made the birth incision.On May 3, 2018, Kimbe
Buckle up, you're in for a wild ride.View Entire Post ›
Unfortunately, disturbing new data from the Center for Retirement Research (CRR) found millions of older Americans are woefully underprepared for one big expense that could be the largest cost they face — and the most crucial one to cover. According to CRR's data, around one-third of all retirees are currently lacking the funds to cover even minimal long-term care services.
KPIX 5's Anne Makovec asks Dr. Laleh Gharahbaghian, medical director of Adult Emergency Medicine at Stanford Hospital, if COVID-19 vaccines will become a 3-dose situation from now on, now that the CDC is expanding eligibility for booster shots to all adults
Top U.S. infectious disease official Dr. Anthony Fauci said on Tuesday the vast majority of Americans who have been vaccinated against COVID-19 should receive a booster shot, and that an additional dose could eventually become the country's standard for determining who is fully vaccinated. Fauci and other disease experts have said they expect that COVID-19 will transition this spring from a pandemic phase in the United States to an endemic disease, meaning that the virus will continue to circulate at a lower level, causing smaller, less disruptive but still significant outbreaks in the coming years. But some are expressing new concern over a rise in U.S. infections in recent weeks, a trend that is likely to accelerate as more Americans travel and gather for U.S. Thanksgiving this week and other upcoming holidays.
Here's a look at the latest COVID-19 numbers for Ohio.
Last week I was in Waitrose, doing my food shopping. Bare-faced and mask-free, I spied an old friend. As I wheeled my trolley over to her, smiling, our eyes met for a millisecond, before she looked off in the other direction and scurried off, disappearing – pink mask and all – into the frozen food aisle.
Janelle Goins was watching TV one evening when she discovered a small nodule in one of her breasts. But she didn’t feel overly concerned because she’s had cysts in the past.

Connect with Chris Hood, a digital strategist that can help you with AI.

Leave a Reply

Your email address will not be published. Required fields are marked *

© 2021 AI Caosuo - Proudly powered by theme Octo